Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $1.4 million.

  • Upstream Bio's Change in Account Payables rose 90517.24% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$926000.0, marking a year-over-year decrease of 11993.54%. This contributed to the annual value of $2.0 million for FY2024, which is 5782.47% up from last year.
  • Latest data reveals that Upstream Bio reported Change in Account Payables of $1.4 million as of Q3 2025, which was up 90517.24% from -$2.2 million recorded in Q2 2025.
  • Upstream Bio's 5-year Change in Account Payables high stood at $3.7 million for Q2 2024, and its period low was -$2.2 million during Q2 2025.
  • For the 3-year period, Upstream Bio's Change in Account Payables averaged around $464875.0, with its median value being $268500.0 (2024).
  • Over the last 5 years, Upstream Bio's Change in Account Payables had its largest YoY gain of 90517.24% in 2025, and its largest YoY loss of 15893.39% in 2025.
  • Quarter analysis of 3 years shows Upstream Bio's Change in Account Payables stood at $1.8 million in 2023, then tumbled by 149.57% to -$871000.0 in 2024, then surged by 260.85% to $1.4 million in 2025.
  • Its Change in Account Payables stands at $1.4 million for Q3 2025, versus -$2.2 million for Q2 2025 and $711000.0 for Q1 2025.